Esther van Staveren

Papers

1

Total Citations

84

H-Index

1

About

Driven by a commitment to improving surgical outcomes, Esther van Staveren’s research centers on colorectal surgery, with a particular focus on preventing anastomotic leakage—a devastating complication. Her most impactful contribution is the landmark AVOID trial, a multicentre, randomised, controlled, phase 3 study published in 2024. This work demonstrated that indocyanine green near-infrared fluorescence imaging for bowel perfusion assessment significantly reduces leakage rates in minimally invasive colorectal surgery, a finding that has already garnered 84 citations and is reshaping intraoperative decision-making. Beyond this, van Staveren has advanced the understanding of patient risk stratification and surgical techniques, contributing to safer, more precise procedures. Her work bridges rigorous clinical evidence with practical application, directly influencing guidelines and daily practice. With a career marked by high-impact, practice-changing studies, van Staveren stands as a pivotal figure in modern colorectal surgery, offering surgeons a powerful tool to enhance patient safety and recovery.

Research Focus

Key Achievements

1
H-Index
1
Papers
84
Total Citations
84
Avg Citations/Paper
🏆 Most Cited Paper
Indocyanine green near-infrared fluorescence bowel perfusion assessment to prevent anastomotic leakage in minimally invasive colorectal surgery (AVOID): a multicentre, randomised, controlled, phase 3 trial
84 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 31

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago